Butylboronic acid

Butylboronic acid is a competitive soybean urease inhibitor with an IC50 of 2.9 mM and a Ki of 1.5 mM[1].

Product Specifications

CAS Number

[4426-47-5]

UNSPSC

12352211

Hazard Statement

H227, H315, H319, H335

Target

Phosphatase; Urease

Type

Reference compound

Related Pathways

Anti-infection; Metabolic Enzyme/Protease

Applications

COVID-19-immunoregulation

Field of Research

Endocrinology

Assay Protocol

https://www.medchemexpress.com/butylboronic-acid.html

Purity

99.99

Solubility

DMSO : ≥ 200 mg/mL

Smiles

CCCCB(O)O

Molecular Formula

C4H11BO2

Molecular Weight

101.94

Precautions

H227, H315, H319, H335

References & Citations

[1]Sandeep Kumar, et al. Inhibition studies of soybean (Glycine max) urease with heavy metals, sodium salts of mineral acids, boric acid, and boronic acids. J Enzyme Inhib Med Chem. 2010 Oct;25 (5) :646-52.|[2]Nakano T, et al. Butylboronic acid promotes cell proliferation, alkaline phosphatase activity, and expression of GJA1, ALP, and NaBC1 in human dental pulp cells in vitro. Front Dent Med. 2025 Feb 11;6:1518389.